Kurt J. Andrews serves as Executive at AMICUS THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Kurt J. Andrews has executed 9 insider transactions totaling $296.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 2, 2018 involved exercising options for 5,000 shares valued at $30.6K.
Kurt J. Andrews currently holds 40,469 shares of AMICUS THERAPEUTICS INC (FOLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kurt J. Andrews has been a net seller of FOLD stock. They have purchased $0 and sold $296.7K worth of shares.
Kurt J. Andrews's most recent insider trade was on Jul 2, 2018, when they sold 5,000 shares at $6.13 per share.
Get notified when new Form 4 filings are submitted
| $15.63 |
| Discretionary |
| Apr 2, 2018 | FOLD | $71.3K | Sale | 5,000 | $14.27 | Discretionary |
| Apr 2, 2018 | FOLD | $30.6K | Option Exercise | 5,000 | $6.13 | Discretionary |
| Jan 3, 2018 | FOLD | $0 | Award | 5,732 | $N/A | Discretionary |
| Jan 2, 2018 | FOLD | $147.2K | Sale | 10,000 | $14.72 | Discretionary |
| Jan 2, 2018 | FOLD | $147.2K | Option Exercise | 10,000 | $14.72 | Discretionary |
| Jan 3, 2017 | FOLD | $0 | Award | 30,487 | $N/A | Discretionary |
| Jun 15, 2016 | FOLD | $0 | Award | 4,250 | $N/A | Discretionary |